From Formulation Concepts to Market-Ready Products

Our Development Portfolio

We strategically select our portfolio to enable our program management and technical teams to design rapid and risk-mitigated development pathways for each product. This approach allows us to move quickly through or even avoid early-phase studies, and accelerate progress to pivotal clinical assessments and successful submissions. Each of our distinctive, high-quality products delivers enhanced value to patients through our formulation optimization and unique technology applications. Banner Life Sciences™ is rapidly executing a dynamic portfolio of products across diverse therapeutic areas and our Ideation Advisory Board continues to evaluate future candidates for portfolio addition.

Product Development

Banner Life Sciences’ fully integrated product-development team of experienced formulators, analytical scientists, clinical affairs and regulatory specialists work to create novel formulations for products that meet patient needs. Historically a softgel company, our product portfolio is expanded and incorporates multiple-dosage platforms and capabilities, including tablets and sterile injectables. Each of our development products is strategically selected with a formulation approach, which applies proprietary technologies to create valuable solutions. Our product-development team is driven by a commitment to both quality and speed, taking products from bench to commercial process validation smoothly and efficiently.